{"abstract": "JPMorgan stands to earn $55 million to $65 million in fees for advising Forest Laboratories in its acquisition by Actavis, according to estimates from Freeman & Company.", "web_url": "https://dealbook.nytimes.com/2014/02/18/another-big-windfall-for-jpmorgan-in-drug-maker-deal/", "snippet": "JPMorgan stands to earn $55 million to $65 million in fees for advising Forest Laboratories in its acquisition by Actavis, according to estimates from Freeman & Company.", "lead_paragraph": "Actavis\u2019s deal to acquire the drug maker Forest Laboratories means significant fees for JPMorgan Chase, the bank\u2019s second apparent windfall in less than a week from advising on a big-ticket deal.", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/02/19/business/dbpix-drug2/dbpix-drug2-articleLarge.jpg", "height": 900, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2014/02/19/business/dbpix-drug2/dbpix-drug2-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 900}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/02/19/business/dbpix-drug2/dbpix-drug2-jumbo.jpg", "height": 1024, "width": 683, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/02/19/business/dbpix-drug2/dbpix-drug2-superJumbo.jpg", "height": 1336, "width": 891, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2014/02/19/business/dbpix-drug2/dbpix-drug2-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2014/02/19/business/dbpix-drug2/dbpix-drug2-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/02/19/business/dbpix-drug2/dbpix-drug2-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Another Big Windfall for JPMorgan in Drug Maker Deal", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Banking and Financial Institutions", "rank": 1, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Actavis Group", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Forest Laboratories Inc", "rank": 4, "major": "N"}, {"name": "organizations", "value": "JPMorgan Chase & Company", "rank": 5, "major": "N"}], "pub_date": "2014-02-18T15:04:49+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Rachel Abrams", "person": [{"firstname": "Rachel", "middlename": null, "lastname": "Abrams", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/5683de9e-331c-5f9f-b2ac-71e1da783a08", "word_count": 304, "uri": "nyt://article/5683de9e-331c-5f9f-b2ac-71e1da783a08"}